Roland H Wenger Selected Research

oxalylglycine

1/2017	Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation.
7/2013	Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36.
11/2007	Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland H Wenger Research Topics

Disease

79	Hypoxia (Hypoxemia) 11/2022 - 01/2002
22	Neoplasms (Cancer) 12/2020 - 05/2002
6	Inflammation (Inflammations) 11/2022 - 08/2015
6	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2013
5	Anemia 01/2022 - 03/2004
3	Chronic Renal Insufficiency 01/2020 - 10/2019
3	Polycythemia (Erythrocytosis) 10/2013 - 06/2010
2	Triple Negative Breast Neoplasms 05/2016 - 09/2013
2	primary familial and congenital Polycythemia 10/2013 - 01/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2013 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 06/2005 - 02/2002
1	Ischemia 11/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Neuroblastoma 08/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021
1	Fibrosis (Cirrhosis) 05/2021
1	Colonic Neoplasms (Colon Cancer) 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Ureteral Obstruction 10/2020
1	Reperfusion Injury 01/2020
1	Iron Deficiencies 10/2018
1	Crohn Disease (Crohn's Disease) 01/2017
1	Colitis 01/2017
1	Neoplasm Metastasis (Metastasis) 08/2015
1	Atherosclerotic Plaque (Atheroma) 07/2013

Drug/Important Bio-Agent (IBA)

38	Oxygen (Dioxygen)IBA 11/2022 - 02/2002
25	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2002
15	Erythropoietin FDA Link 01/2022 - 02/2002
13	Messenger RNA (mRNA)IBA 05/2022 - 05/2002
13	Transcription Factors (Transcription Factor)IBA 01/2016 - 08/2002
9	EnzymesIBA 01/2022 - 05/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2002
6	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 01/2002
5	Mixed Function Oxygenases (Monooxygenases)IBA 11/2022 - 08/2002
5	Protein Isoforms (Isoforms)IBA 10/2006 - 02/2002
4	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2017 - 03/2002
3	AsparagineIBA 11/2022 - 01/2016
3	UbiquitinIBA 01/2017 - 01/2004
3	oxalylglycineIBA 01/2017 - 11/2007
3	LuciferasesIBA 08/2009 - 01/2003
3	IronIBA 09/2003 - 03/2002
2	Insulin (Novolin)FDA Link 01/2022 - 02/2002
2	roxadustatIBA 01/2022 - 01/2022
2	Extracellular Matrix ProteinsIBA 05/2021 - 12/2020
2	Carbon MonoxideIBA 10/2020 - 03/2004
2	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 09/2020 - 06/2013
2	Hormones (Hormone)IBA 12/2019 - 05/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 01/2017
2	ubiquitin-aldehydeIBA 01/2019 - 01/2016
2	DioxygenasesIBA 01/2019 - 06/2014
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2016
2	Deubiquitinating EnzymesIBA 01/2019 - 01/2016
2	Estrogens (Estrogen)FDA Link 01/2017 - 05/2016
2	Phenobarbital (Luminal)FDA Link 01/2014 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 09/2013 - 02/2002
2	Phosphotransferases (Kinase)IBA 09/2013 - 08/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2013 - 09/2004
2	AntigensIBA 06/2013 - 01/2011
2	Biological ProductsIBA 06/2012 - 04/2009
2	CollagenIBA 05/2011 - 10/2007
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2007 - 01/2004
2	geldanamycinIBA 12/2005 - 03/2002
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 03/2004 - 05/2003
2	Adenosine Triphosphate (ATP)IBA 08/2003 - 03/2002
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 05/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Excipients (Suspending Agents)IBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 08/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 08/2021
1	Radiation-Sensitizing AgentsIBA 06/2021
1	SodiumIBA 05/2021
1	Dextrans (Dextran)FDA Link 05/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2020
1	CytoglobinIBA 01/2020
1	Phosphates (Orthophosphate)IBA 10/2019
1	CytokinesIBA 10/2019
1	Fibroblast Growth Factor-23IBA 10/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	PeroxidesIBA 01/2019
1	InterleukinsIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Dextran SulfateIBA 01/2017
1	pimonidazoleIBA 01/2017
1	NucleotidesIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	Estrogen Receptor alphaIBA 05/2016
1	human ERBB2 proteinIBA 05/2016
1	IntegrinsIBA 03/2016
1	ChromatinIBA 07/2015
1	GasesIBA 01/2015
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2014
1	Scavenger Receptors (Scavenger Receptor)IBA 07/2013
1	LipidsIBA 07/2013

Therapy/Procedure

8	Therapeutics 08/2015 - 05/2003
3	Radiotherapy 06/2021 - 05/2003
3	Drug Therapy (Chemotherapy) 04/2013 - 05/2003
2	Ligation 12/2020 - 01/2017
1	Adjuvant Chemotherapy 09/2014